Published in Am Rev Respir Dis on June 01, 1990
The role of alveolar macrophages in Pneumocystis carinii degradation and clearance from the lung. J Clin Invest (1997) 1.76
AIDS and the lung: update 1992. 2. Recent developments in the management of the pulmonary complications of HIV disease. Thorax (1992) 1.72
Vitronectin binds to Pneumocystis carinii and mediates organism attachment to cultured lung epithelial cells. Infect Immun (1993) 1.28
Molecular characterization of clustered variants of genes encoding major surface antigens of human Pneumocystis carinii. Infect Immun (1994) 1.26
AIDS and the lung: update 1995. 2. New developments in the pulmonary diseases affecting HIV infected individuals. Thorax (1995) 1.26
Surfactant protein D interacts with Pneumocystis carinii and mediates organism adherence to alveolar macrophages. J Clin Invest (1995) 1.24
Pneumocystis carinii glycoprotein A binds macrophage mannose receptors. Infect Immun (1995) 1.18
HIV infection is associated with reduced pulmonary diffusing capacity. J Acquir Immune Defic Syndr (2013) 1.07
Gamma interferon stimulates rat alveolar macrophages to kill Pneumocystis carinii by L-arginine- and tumor necrosis factor-dependent mechanisms. Infect Immun (1999) 0.93
The spectrum of clinical and pathological manifestations of AIDS in a consecutive series of 236 autopsied cases in mumbai, India. Patholog Res Int (2011) 0.93
Serum titres of Pneumocystis carinii antibody in health care workers caring for patients with AIDS. Thorax (1993) 0.91
Quantitative and qualitative comparison of DNA amplification by PCR with immunofluorescence staining for diagnosis of Pneumocystis carinii pneumonia. J Clin Pathol (1993) 0.89
HIV-Related Lung Disorders. Drug Discov Today Dis Mech (2007) 0.88
Effect of bacterial pneumonia on lung simian immunodeficiency virus (SIV) replication in alcohol consuming SIV-infected rhesus macaques. Alcohol Clin Exp Res (2013) 0.86
HIV gp120 induces mucus formation in human bronchial epithelial cells through CXCR4/α7-nicotinic acetylcholine receptors. PLoS One (2013) 0.83
Risk Factors Associated With Quantitative Evidence of Lung Emphysema and Fibrosis in an HIV-Infected Cohort. J Acquir Immune Defic Syndr (2016) 0.82
Pulmonary complications of HIV disease: 10 year retrospective evaluation of yields from bronchoalveolar lavage, 1983-93. Thorax (1995) 0.82
Intensive care for advanced HIV disease. Genitourin Med (1992) 0.81
Respiratory Complications in Iranian Hospitalized Patients with HIV/AIDS. Tanaffos (2011) 0.78
Measurement of antiretroviral drugs in the lungs of HIV-infected patients. HIV Ther (2010) 0.76
Proteomic landscape of bronchoalveolar lavage fluid in human immunodeficiency virus infection. Am J Physiol Lung Cell Mol Physiol (2013) 0.76
How histopathology can contribute to an understanding of defense mechanisms against cryptococci. Mediators Inflamm (2013) 0.76
Lung microbiome in human immunodeficiency virus infection. Transl Res (2016) 0.75
Massive gastrointestinal bleeding in AIDS patients secondary to histoplasma and cytomegalovirus infection. Int J Surg Case Rep (2016) 0.75
Opportunistic infections in HIV-infected patients. Can J Infect Dis (1992) 0.75
Tuberculosis and HIV infection. BMJ (1991) 0.75
Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science (1995) 10.02
The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet (2008) 6.50
Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome. Ann Intern Med (1984) 4.64
An in vitro colony assay for human tumours grown in immune-suppressed mice and treated in vivo with cytotoxic agents. Br J Cancer (1978) 3.82
The natural history of Hendra and Nipah viruses. Microbes Infect (2001) 3.77
Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Clinical findings, diagnosis, and treatment. Ann Intern Med (1988) 3.49
Experimental respiratory syncytial virus infection of adults. Possible mechanisms of resistance to infection and illness. J Immunol (1971) 3.33
The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol (2008) 3.31
Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. A report from the Sydney Blood Bank Cohort. N Engl J Med (1999) 3.30
Isolation of AIDS-associated retroviruses from cerebrospinal fluid and brain of patients with neurological symptoms. Lancet (1985) 2.88
Prospective study of chlamydial infection in neonates. Lancet (1979) 2.80
Human immunodeficiency virus type 1 replication is blocked prior to reverse transcription and integration in freshly isolated peripheral blood monocytes. J Virol (1996) 2.75
Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome. N Engl J Med (1989) 2.56
Development of allergy in children. I. Association with virus infections. J Allergy Clin Immunol (1979) 2.48
Maternal smoking, alcohol drinking, caffeine consumption, and fetal growth: results from a prospective study. Epidemiology (1995) 2.41
Dapsone-trimethoprim for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Ann Intern Med (1986) 2.36
Influence of immunological factors in respiratory syncytial virus disease. Arch Environ Health (1970) 2.30
Comparison of direct immunofluorescence and direct immunoperoxidase procedures for detection of herpes simplex virus antigen in lesion specimens. J Clin Microbiol (1983) 2.27
Pneumocystis carinii and Toxoplasma gondii infections in patients with AIDS. Rev Infect Dis (1987) 2.19
British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE. Thorax (2013) 2.17
Interferon therapy for condylomata acuminata. N Engl J Med (1986) 2.16
Incidence and epidemiology of nosocomial infections in patients infected with human immunodeficiency virus. Clin Infect Dis (1997) 2.14
Infectious complications with respiratory pathogens despite ciprofloxacin therapy. N Engl J Med (1991) 2.12
NHLBI workshop summary. Pulmonary complications of the acquired immunodeficiency syndrome: an update. Report of the second National Heart, Lung and Blood Institute workshop. Am Rev Respir Dis (1987) 2.09
Dobutamine: development of a new catecholamine to selectively increase cardiac contractility. Circ Res (1975) 2.02
Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcome. N Engl J Med (1985) 1.99
Mild cognitive impairment in prediagnosed Huntington disease. Neurology (2010) 1.96
Review of University of British Columbia Family Practice Resident Research Projects 1990-1997. Fam Med (1999) 1.94
A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group. N Engl J Med (1991) 1.89
Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone. N Engl J Med (1990) 1.89
Quantitative immunocytofluorographic analysis of CD4 surface antigen expression and HIV infection of human peripheral blood monocyte/macrophages. AIDS Res Hum Retroviruses (1987) 1.86
Active site mutagenesis of the AIDS virus protease and its alleviation by trans complementation. EMBO J (1988) 1.80
Respiratory syncytial virus neutralizing activity in nasal secretions following natural infection. Proc Soc Exp Biol Med (1969) 1.79
Temperature-sensitive mutants of influenza virus. I. Behavior in tissue culture and in experimental animals. J Infect Dis (1971) 1.78
Mechanisms of platelet aggregation by viridans group streptococci. Infect Immun (1987) 1.77
Long-term acyclovir suppression of frequently recurring genital herpes simplex virus infection. A multicenter double-blind trial. JAMA (1988) 1.76
Comparative study of 5% permethrin cream and 1% lindane lotion for the treatment of scabies. Arch Dermatol (1990) 1.72
Pulmonary infectious complications of human immunodeficiency virus infection. Part I. Am Rev Respir Dis (1990) 1.71
Failure of a once-daily regimen of cefonicid for treatment of endocarditis due to Staphylococcus aureus. Rev Infect Dis (1985) 1.66
Bronchial hyperresponsiveness in normal subjects during attenuated influenza virus infection. Am Rev Respir Dis (1991) 1.64
The human tumour xenograft--a valid model in experimental chemotherapy? Br J Surg (1980) 1.63
Risk of infection after penetrating abdominal trauma. N Engl J Med (1984) 1.60
Experimental asbestosis with four types of fibers: importance of small particles. Ann N Y Acad Sci (1965) 1.55
Use of laparoscopy to determine the microbiologic etiology of acute salpingitis. Am J Obstet Gynecol (1979) 1.52
Influenza in patients with human immunodeficiency virus infection. Chest (1990) 1.50
Correlation between response to acyclovir and foscarnet therapy and in vitro susceptibility result for isolates of herpes simplex virus from human immunodeficiency virus-infected patients. Antimicrob Agents Chemother (1994) 1.50
Comparison of the Western immunoblot assay and a glycoprotein G enzyme immunoassay for detection of serum antibodies to herpes simplex virus type 2 in patients with AIDS. J Clin Microbiol (1992) 1.49
Nine episodes of infective endocarditis in one patient--a new record. West J Med (1987) 1.48
Dapsone, trimethoprim, and sulfamethoxazole plasma levels during treatment of Pneumocystis pneumonia in patients with the acquired immunodeficiency syndrome (AIDS). Evidence of drug interactions. Ann Intern Med (1989) 1.48
Growth of human tumour cell colonies from biopsies using two soft-agar techniques. Br J Cancer (1978) 1.46
Exopolysaccharide production by viridans streptococci in experimental endocarditis. Infect Immun (1984) 1.45
Foscarnet treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome. Antimicrob Agents Chemother (1989) 1.41
Intraoperative high dose rate brachytherapy in recurrent or metastatic colorectal carcinoma. Ann Surg Oncol (1998) 1.39
Hypomagnesaemia in a calf. Vet Rec (1992) 1.38
Serratia marcescens endocarditis: a regional illness associated with intravenous drug abuse. Ann Intern Med (1976) 1.37
Evaluation of influenza virus mutants for possible use in a live virus vaccine. Bull World Health Organ (1969) 1.37
Evaluation of an interferon inducer in viral respiratory disease. JAMA (1972) 1.37
Diagnostic X-ray and ultrasound exposure and risk of childhood cancer. Br J Cancer (1994) 1.36
Hantavirus reservoir hosts associated with peridomestic habitats in Argentina. Emerg Infect Dis (2000) 1.36
Surface CD4 is critical to in vitro HIV infection of human alveolar macrophages. AIDS Res Hum Retroviruses (1996) 1.35
Enzymatic modification of glycocalyx in the treatment of experimental endocarditis due to viridans streptococci. J Infect Dis (1987) 1.33
Prolonged use of methyldopa in severe hypertension in pregnancy. Br Med J (1966) 1.31
In vitro radiation response of cells from four human tumors propagated in immune-suppressed mice. Cancer Res (1978) 1.31
Effect of Foscarnet therapy on infection with human immunodeficiency virus in patients with AIDS. J Infect Dis (1988) 1.30
In vitro comparison of third-generation cephalosporins, piperacillin, dibekacin, and other aminoglycosides against aerobic bacteria. Antimicrob Agents Chemother (1981) 1.29
Forecasting the future of HIV epidemics: the impact of antiretroviral therapies & imperfect vaccines. AIDS Rev (2003) 1.28
Release of interleukin 1 inhibitory activity (contra-IL-1) by human monocyte-derived macrophages infected with human immunodeficiency virus in vitro and in vivo. J Clin Invest (1988) 1.26
Incidence of acute mountain sickness at intermediate altitude. JAMA (1989) 1.25
Prognosis in cystic fibrosis treated with continuous flucloxacillin from the neonatal period. Arch Dis Child (1994) 1.25
Respiratory syncytial virus matrix protein associates with nucleocapsids in infected cells. J Gen Virol (2002) 1.24
Enhanced cell killing in lewis lung carcinoma and a human pancreatic-carcinoma xenograft by the combination of cytotoxic drugs and misonidazole. Br J Cancer (1981) 1.23
Isolation and characterization of a multipotent clone of human embryonal carcinoma cells. Differentiation (1989) 1.23
Cultured stem-cells from human testicular teratomas: the nature of human embryonal carcinoma, and its comparison with two types of yolk-sac carcinoma. Int J Cancer (1987) 1.22
Ganciclovir for the treatment and suppression of serious infections caused by cytomegalovirus. Am J Med (1987) 1.22
Effectiveness of nurse triage in the emergency department of an urban county hospital. JACEP (1976) 1.22
Topoisomerase I phosphorylation in vitro and in rapidly growing Novikoff hepatoma cells. EMBO J (1985) 1.21
HIV-1 DNA and mRNA concentrations are similar in peripheral blood monocytes and alveolar macrophages in HIV-1-infected individuals. AIDS (1998) 1.21
Temperature-sensitive mutants of influenza virus. VI. Transfer of TS lesions from the Asian subtype of influenza A virus (H2N2) to the Hong Kong subtype (H3N2). Virology (1975) 1.20
An examination of signs of disease progression in survivors of the Sydney Blood Bank Cohort (SBBC). J Clin Virol (2001) 1.19
Client-centred practice: what does it mean and does it make a difference? Can J Occup Ther (1995) 1.19
Experimental asbestosis in the guinea-pig. J Pathol Bacteriol (1966) 1.19
Human immunodeficiency virus type 1 Nef binds directly to Lck and mitogen-activated protein kinase, inhibiting kinase activity. J Virol (1996) 1.18
Zidovudine resistance is suppressed by mutations conferring resistance of human immunodeficiency virus type 1 to foscarnet. J Virol (1996) 1.18
Randomized prospective trial of ganciclovir maintenance therapy for cytomegalovirus retinitis. J Med Virol (1988) 1.16
Ceftizoxime for treatment of gonorrhoea. J Antimicrob Chemother (1982) 1.16
Cefuroxime axetil for treatment of uncomplicated gonorrhea. Antimicrob Agents Chemother (1986) 1.14
The role of histamine receptors in asthma. Clin Sci (Lond) (1981) 1.13
Pharmacokinetics of intermittently administered intravenous foscarnet in the treatment of acquired immunodeficiency syndrome patients with serious cytomegalovirus retinitis. Antimicrob Agents Chemother (1989) 1.13
Comparison of the human immunodeficiency virus type 1 and 2 proteases by hybrid gene construction and trans-complementation. J Biol Chem (1989) 1.13
Deciphering serology to understand the ecology of infectious diseases in wildlife. Ecohealth (2013) 1.12
Demethylation studies. VI. The inhibition of hepatic microsomal oxygenation by 2,4-dichloro(6-phenylphenoxy)ethylamine and related compounds. J Med Chem (1969) 1.12
Foscarnet therapy in five patients with AIDS and acyclovir-resistant varicella-zoster virus infection. Ann Intern Med (1991) 1.11
Immunoblot analysis of the humoral immune response in primary cytomegalovirus infection. J Infect Dis (1988) 1.11
HIV infection of monocyte-derived macrophages in vitro reduces phagocytosis of Candida albicans. J Leukoc Biol (1994) 1.11
Anhidrotic ectodermal dysplasia presenting as a pyrexia of undertermined origin in the neonatal period. Postgrad Med J (1968) 1.10
Effectiveness and acceptability of a newly designed hip protector: a pilot study. Arch Gerontol Geriatr (2004) 1.10
Specific inhibition of human immunodeficiency virus type 1 (HIV-1) integration in cell culture: putative inhibitors of HIV-1 integrase. Antimicrob Agents Chemother (2001) 1.09
Foscarnet therapy for severe acyclovir-resistant herpes simplex virus type-2 infections in patients with the acquired immunodeficiency syndrome (AIDS). An uncontrolled trial. Ann Intern Med (1989) 1.08